SEMA4C and neoplasm: To demonstrate the tumor-promoting role of SEMA4C in CRC, we developed knockdown vectors for SEMAC4 (si-SEMA4C#1, si-SEMA4C#2) alongside RNAi negative control vectors (si-NC) and transfected them into HT29 and SW480 cell lines.